Doctor profile · Federal record
Dr. Jodi Crouse, AGPCNP
Nurse Practitioner · Registered Nurse · Elmira, NY
- NPI 1770003428
- Accepts Medicare
- MIPS 78.1 / 100 · 2023
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
200 Madison Ave Ste 1D
Elmira, NY 149013219
(607) 873-1832
fax (607) 873-1833 - Mailing address
-
571 Saint Josephs Blvd Fl 2
Elmira, NY 149013230
Credentials & registration
- NPI registered
- June 2017 — 9 yrs on file
- Profile last updated
- November 24, 2020
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State licenses (2)
- New York #308427 · New York #547671
- Medicaid
- NY #04966607
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1770003428. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
970
Distinct HCPCS
8
Medicare allowed
$37,911
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 282 | 70 | $2 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 211 | 161 | $81 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 162 | 134 | $55 | |
17000 |
Destruction of precancer skin growth, 1 growth | 122 | 101 | $40 | |
17110 |
Destruction of skin growth, 1-14 growths | 73 | 62 | $55 | |
11102 |
Biopsy of related skin growth, first growth | 72 | 67 | $23 | |
11103 |
Biopsy of related skin growth, each additional growth | 31 | 22 | $18 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 17 | 17 | $29 |
In context: peer comparison
Among 13 peers in Elmira Nurse Practitioner, average services per provider: 130. This provider delivers 7.5× the peer median.Open Payments
Industry payments received
All-time total
$865
Transactions
49
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dermavant Sciences, INC. | 18 | $238.93 | |
| Abbvie INC. | 5 | $102.83 | |
| Novartis Pharmaceuticals Corporation | 4 | $74.49 | |
| Lilly USA, LLC | 3 | $63.88 | |
| Biofrontera INC. | 3 | $50.29 | |
| Amgen INC. | 2 | $49.26 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 2 | $41.84 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $39.87 | |
| Janssen Biotech, INC. | 2 | $39.82 | |
| Sun Pharmaceutical Industries INC. | 2 | $37.03 | |
| Genzyme Corporation | 1 | $31.66 | |
| Arcutis Biotherapeutics, INC. | 2 | $30.80 | |
| Ucb, INC. | 1 | $24.88 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 1 | $20.16 | |
| Regeneron Healthcare Solutions, INC. | 1 | $19.15 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
644
Patients
382
Total drug cost
$164,923
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 137 | 65 | $2,159 |
| Triamcinolone Acetonide | Generic | 108 | 79 | $1,511 |
| Clobetasol Propionate | Generic | 71 | 43 | $6,615 |
| Mupirocin | Generic | 52 | 46 | $461 |
| Dupixent Pen (Dupilumab) | Brand | 37 | 0 | $136,928 |
| Metronidazole | Generic | 33 | 17 | $3,534 |
| Doxycycline Hyclate | Generic | 32 | 20 | $479 |
| Ciclopirox | Generic | 31 | 12 | $1,275 |
| Clindamycin Phosphate | Generic | 27 | 16 | $2,071 |
| Imiquimod | Generic | 25 | 25 | $1,228 |
Hospital affiliations
Frequently asked questions
What is Dr. Jodi Crouse's medical specialty?
Dr. Jodi Crouse practices Nurse Practitioner in Elmira, NY.
Where does Dr. Jodi Crouse practice?
Dr. Jodi Crouse practices at 200 Madison Ave Ste 1D, Elmira, NY 149013219. Office phone: 6078731832.
What is Dr. Jodi Crouse's NPI?
Dr. Jodi Crouse's National Provider Identifier (NPI) is 1770003428, issued by NPPES.
Does Dr. Jodi Crouse accept Medicare assignment?
Yes. Dr. Jodi Crouse accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jodi Crouse commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.